New York City, NY -- (SBWIRE) -- 08/20/2013 -- StockMarketIntel.com issues a special report on the following stocks: Coeur d'Alene Mines Corporation (NYSE:CDE), Exelixis, Inc. (NASDAQ:EXEL), Vical Incorporated (NASDAQ:VICL), Aastrom Biosciences Inc (NASDAQ:ASTM)
Coeur d'Alene Mines Corporation (NYSE:CDE) declined -3.45%, trading on 1.76M shares to end the trade at $15.37. The stock changed hands in a range of $15.30 to $16.02, bringing its market capitalization at about $1.56B. If we look at its trading history of past 52 weeks, the share price suffered low of $11.29 on Jul 9, 2013 and was moved to maximum level of $31.97 on Nov 1, 2012. Coeur Mining, Inc., formerly Coeur d’Alene Mines Corporation, is a silver producer with gold production and has assets located in the United States, Mexico, Bolivia, Argentina and Australia.
Has CDE Found The Bottom and Ready To Move Up? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) loss of -0.61% to complete the trading session at $4.88 with a total volume of 1.75M shares. The stock, on average, trades on a volume of 1.97M shares. It floated in a range of $4.88 to $5.05 during last trading session with a beta value of 1.94. Its market capitalization now moved to about $898.49M. In the past 52 weeks, the share price has not declined below $4.19 and above $5.56. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184).
Has EXEL Found The Bottom And Ready To Gain Momentum? Find Out Here
Vical Incorporated (NASDAQ:VICL) traded was in a range of $1.38 -$1.46 before closing at $1.40. The stock completed the day with a total volume of 1.74M shares versus an average volume of 2.90M shares. The share pricehit its 52-week low of $1.37 on Aug 12, 2013 and $4.74 was the best price in the same period. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
How Should Investors Trade VICL Now? Don’t Miss out a Special Trend Analysis
Aastrom Biosciences Inc (NASDAQ:ASTM) loss of -0.33% yesterday, bringing its market capitalization around $22.70M. The share price after opening at $0.31 made a high of $0.32 and hovered above $0.30 to end the day at $0.304. The total number of shares changed hands during the session was 1.72M shares as compared to average trading volume of 1.83M shares. Aastrom Biosciences, Inc. (Aastrom) is a development-stage company. The Company is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues.
Will ASTM Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)